Director's Dealing • Jun 22, 2020
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 6954Q
Mediclinic International plc
22 June 2020
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", or the "Company", or the "Group")
22 June 2020
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
On 19 June 2020, Mr Gert Hattingh, Group Chief Corporate Services Officer of Mediclinic International plc, sold a total of 25 904 shares in the Company to cover personal tax liabilities. Mr Hattingh continues to hold 100 000 shares in the Company.
The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Ghwarriebos Investments (Pty) Ltd
2.
Reason for the notification
a)
Position / status
PCA of Mr Gert Cornelis Hattingh, Group Chief Corporate Services Officer
b)
Initial notification / amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Mediclinic International plc
b)
LEI
2138002S5BSBIZTD5I60
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Identification Code
Ordinary Shares
GB00B8HX8Z88
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) per share | Volume(s) |
| ZAR 58.37 | 4 000 |
| ZAR 58.43 | 3 000 |
| ZAR 58.46 | 3 055 |
| ZAR 58.47 | 1 904 |
| ZAR 58.48 | 945 |
| ZAR 58.50 | 4 000 |
| ZAR 58.55 | 2 000 |
| ZAR 58.58 | 3 000 |
| ZAR 58.73 | 3 500 |
| ZAR 58.74 | 500 |
d)
Aggregated information
Aggregated volume
Price
25 904
ZAR 58.51 per share
e)
Date of the transaction
19 June 2020; 11:12 UTC
f)
Place of the transaction
Johannesburg Stock Exchange
About Mediclinic International plc
Mediclinic is an international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates ("UAE").
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
At 1 June 2020, Mediclinic comprised 76 hospitals, eight sub-acute and specialised hospitals, 15 day case clinics and 21 outpatient clinics. Hirslanden operated 17 hospitals, three day case clinics and three outpatient clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operations included 52 hospitals (three of which in Namibia), eight sub-acute and specialised hospitals and 10 day case clinics (four of which operated by Intercare) across South Africa, and more than 8 700 inpatient beds; and Mediclinic Middle East operated seven hospitals, two day case clinics and 18 outpatient clinics with more than 900 inpatient beds in the UAE.
The Company's primary listing is on the London Stock Exchange ("LSE") in the United Kingdom, with secondary listings on the JSE Ltd in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Caroline Emmet
+44 (0)20 7954 9548
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
+44 (0)20 3786 8181
Media queries
FTI Consulting
Ben Atwell/Ciara Martin - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker (United Kingdom): Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBSGDLRSDDGGD
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.